Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.
作者信息
Zhang Min, Luo Jin-Li, Sun Qianqian, Harber James, Dawson Alan G, Nakas Apostolos, Busacca Sara, Sharkey Annabel J, Waller David, Sheaff Michael T, Richards Cathy, Wells-Jordan Peter, Gaba Aarti, Poile Charlotte, Baitei Essa Y, Bzura Aleksandra, Dzialo Joanna, Jama Maymun, Le Quesne John, Bajaj Amrita, Martinson Luke, Shaw Jacqui A, Pritchard Catrin, Kamata Tamihiro, Kuse Nathaniel, Brannan Lee, De Philip Zhang Pan, Yang Hongji, Griffiths Gareth, Wilson Gareth, Swanton Charles, Dudbridge Frank, Hollox Edward J, Fennell Dean A
机构信息
Novogene Co., Ltd, Building 301, Beijing, China.
Bioinformatics and Biostatistics Support Hub, University of Leicester, Leicester, UK.
出版信息
Nat Commun. 2021 Jun 7;12(1):3569. doi: 10.1038/s41467-021-23867-6.
Abstract
摘要
相似文献
1
Author Correction: Clonal architecture in mesothelioma is prognostic and shapes the tumour microenvironment.作者更正：间皮瘤中的克隆结构具有预后意义并塑造肿瘤微环境。
Nat Commun. 2021 Jun 7;12(1):3569. doi: 10.1038/s41467-021-23867-6.
2
Temsirolimus targets multiple hallmarks of cancer to impede mesothelioma growth in vivo.替西罗莫司针对癌症的多种特征，阻碍体内间皮瘤的生长。
Respirology. 2015 Nov;20(8):1263-71. doi: 10.1111/resp.12604. Epub 2015 Aug 5.
3
Local effector failure in mesothelioma is not mediated by CD4+ CD25+ T-regulator cells.间皮瘤中的局部效应器功能衰竭并非由CD4 + CD25 + T调节细胞介导。
Eur Respir J. 2009 Jul;34(1):162-75. doi: 10.1183/09031936.00101008. Epub 2009 Feb 27.
4
Malignant cells from pleural fluids in malignant mesothelioma patients reveal novel mutations.恶性间皮瘤患者胸腔液中的恶性细胞揭示了新的突变。
Lung Cancer. 2018 May;119:64-70. doi: 10.1016/j.lungcan.2018.03.009. Epub 2018 Mar 9.
5
ASO Author Reflections: C-Reactive Protein/Albumin Ratio as a Prognostic Factor in Patients with Malignant Pleural Mesothelioma: What Does the Novel Index Represent?
Ann Surg Oncol. 2018 Dec;25(Suppl 3):958-959. doi: 10.1245/s10434-018-6920-9. Epub 2018 Oct 23.
6
Stromal tumour-infiltrating lymphocytes (TILs) assessed using the ITWG system do not predict overall survival in a cohort of 337 cases of mesothelioma.使用国际工作组（ITWG）系统评估的基质肿瘤浸润淋巴细胞（TILs）不能预测337例间皮瘤患者队列的总生存期。
Histopathology. 2020 Jun;76(7):1095-1101. doi: 10.1111/his.14106. Epub 2020 May 20.
7
[The prospects for the appearance of pleural mesothelioma in Italy].[意大利胸膜间皮瘤出现的前景]
Med Lav. 1991 Mar-Apr;82(2):155-9.
8
Author Correction: LSD1 activation promotes inducible EMT programs and modulates the tumour microenvironment in breast cancer.作者更正：赖氨酸特异性去甲基化酶1（LSD1）激活促进诱导性上皮-间质转化程序并调节乳腺癌肿瘤微环境。
Sci Rep. 2019 Dec 5;9(1):18771. doi: 10.1038/s41598-019-55020-1.
9
Author Correction: Enabling cell recovery from 3D cell culture microfluidic devices for tumour microenvironment biomarker profiling.作者更正：实现从用于肿瘤微环境生物标志物分析的3D细胞培养微流控装置中回收细胞。
Sci Rep. 2020 Jan 15;10(1):757. doi: 10.1038/s41598-020-57830-0.
10
Potential Diagnostic and Prognostic Role of Microenvironment in Malignant Pleural Mesothelioma.恶性胸膜间皮瘤中微环境的潜在诊断和预后作用。
J Thorac Oncol. 2019 Aug;14(8):1458-1471. doi: 10.1016/j.jtho.2019.03.029. Epub 2019 May 9.
引用本文的文献
1
The role of pathologists in the diagnosis of occupational lung diseases: an expert opinion of the European Society of Pathology Pulmonary Pathology Working Group.病理学家在职业性肺部疾病诊断中的作用：欧洲病理学会肺部病理学工作组的专家意见。
Virchows Arch. 2024 Aug;485(2):173-195. doi: 10.1007/s00428-024-03845-1. Epub 2024 Jul 20.
2
Optimized dose selective HDAC inhibitor tucidinostat overcomes anti-PD-L1 antibody resistance in experimental solid tumors.优化剂量的选择性 HDAC 抑制剂 tucidinostat 克服了实验性实体瘤中抗 PD-L1 抗体的耐药性。
BMC Med. 2022 Nov 9;20(1):435. doi: 10.1186/s12916-022-02598-5.
3
Genomic landscape, immune characteristics and prognostic mutation signature of cervical cancer in China.中国宫颈癌的基因组景观、免疫特征和预后突变特征。
BMC Med Genomics. 2022 Nov 4;15(1):231. doi: 10.1186/s12920-022-01376-9.
Zotero 插件